Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00321022 · ClinicalTrials.gov registry record · NA
Transient Ischemic Attack (TIA) Accelerated Diagnostic Protocol
A NA study of Transient Ischemic Attack, sponsored by Corewell Health East.
- Completed
- Registry status
- NA
- Development phase
- 154
- Enrollment target
- 1
- Study location
NCT00321022 is a NA study of Transient Ischemic Attack that has completed, run by Corewell Health East. The registered enrollment target is 154 participants, below the 1,112-participant average among 7 other Transient Ischemic Attack trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00321022, a NA study of Transient Ischemic Attack, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to determine if emergency department patients with Transient Ischemic Attack (TIA) that are managed using a TIA "accelerated diagnostic protocol", or "ADP", demonstrate a significant decrease in their index visit length of stay and cost, with comparable diagnostic and 90-day clinical outcomes relative to TIA patients randomized to traditional inpatient care. The secondary objectives are to evaluate the potential role of a TIA risk stratification tool and to determine the time to a diagnostic endpoint in both groups.
Conditions Studied
Interventions
- BEHAVIORAL Accelerated Diagnostic Protocol Emergency Department Observational Unit
Study Locations (1)
Michigan
- William Beaumont Hospital - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2003-08 |
| Est. Completion | 2005-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00321022
The ClinicalTrials.gov registry entry for NCT00321022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,112-participant average among 7 other Transient Ischemic Attack trials with a reported enrollment target (86% lower). The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Transient Ischemic Attack appearing as the primary indexed condition, and to 1 intervention - of which Accelerated Diagnostic Protocol Emergency Department Observational Unit is the first listed.
NCT00321022 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT00321022 about?
NCT00321022 is a clinical study titled "Transient Ischemic Attack (TIA) Accelerated Diagnostic Protocol". The primary objective of this study is to determine if emergency department patients with Transient Ischemic Attack (TIA) that are managed using a TIA "accelerated diagnostic protocol", or "ADP", demonstrate a significant decrease in their index visit length of stay and cost, with comparable diagnos...
What is the current status of trial NCT00321022?
This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2003-08. Estimated completion is 2005-09.
What conditions does trial NCT00321022 study?
This clinical trial studies the following conditions: Transient Ischemic Attack.
What interventions are being tested in trial NCT00321022?
The interventions under investigation include: Accelerated Diagnostic Protocol Emergency Department Observational Unit (BEHAVIORAL).
Who is sponsoring clinical trial NCT00321022?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00321022 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Transient Ischemic Attack
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
COMPLETED · NA
-
Comprehensive Post-Acute Stroke Services
COMPLETED · NA
-
Reducing Stroke Risk in African-American Men
COMPLETED · NA
-
GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients
COMPLETED · NA
-
Center for Stroke Disparities Solution - Community Transitions Intervention
COMPLETED · NA
-
Florida Cerebrovascular Disease Biorepository and Genomics Center
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.